A transgenic mouse model for in vivo regulation of the human CYP3A4 promoter

被引:0
|
作者
Zhang, WS [1 ]
Purchio, A [1 ]
Chen, K [1 ]
Wu, JM [1 ]
Lu, L [1 ]
West, DB [1 ]
机构
[1] Xenogen Corp, Alameda, CA 94501 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
235
引用
收藏
页码:118 / 118
页数:1
相关论文
共 50 条
  • [1] In vivo differential regulation of the human CYP3A4 promoter in transgenic mice and rats
    Zhang, WS
    Purchio, AF
    Coffee, R
    West, DB
    DRUG METABOLISM REVIEWS, 2003, 35 : 143 - 143
  • [2] A transgenic mouse model with a luciferase reporter for studying in vivo transcriptional regulation of the human CYP3A4 gene
    Zhang, WS
    Purchio, AF
    Chen, K
    Wu, JM
    Lu, L
    Coffee, R
    Contag, PR
    West, DB
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (08) : 1054 - 1064
  • [3] Transgenic mouse models of human CYP3A4 gene regulation
    Robertson, GR
    Field, J
    Goodwin, B
    Bierach, S
    Tran, M
    Lehnert, A
    Liddle, C
    MOLECULAR PHARMACOLOGY, 2003, 64 (01) : 42 - 50
  • [4] Differential regulation of the human CYP3A4 promoter in transgenic mice and rats
    Zhang, WS
    Purchio, AF
    Coffee, R
    West, DB
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (02) : 163 - 167
  • [5] In vivo activation of the human CYP3A4 promoter in mouse liver and regulation by pregnane X receptors
    Zhang, WS
    Purchio, A
    Chen, K
    Burns, SM
    Contag, CH
    Contag, PR
    BIOCHEMICAL PHARMACOLOGY, 2003, 65 (11) : 1889 - 1896
  • [6] In vivo activation of the human CYP3A4 promoter in mouse liver and regulation by pregnane X receptors
    Zhang, WS
    Purchio, A
    Chen, K
    Bums, S
    Contag, CH
    Contag, PR
    DRUG METABOLISM REVIEWS, 2002, 34 : 118 - 118
  • [7] Marmoset CYP3A21, a model for human CYP3A4:: Protein expression and functional characterization of the promoter
    Koehler, S. C.
    Von Ahsen, N.
    Schlumbohm, C.
    Asif, A. R.
    Goedtel-Armbrust, U.
    Oellerich, M.
    Wojnowski, L.
    Armstrong, V. W.
    XENOBIOTICA, 2006, 36 (12) : 1210 - 1226
  • [8] Lessons from the CYP3A4 promoter
    Schuetz, EG
    MOLECULAR PHARMACOLOGY, 2004, 65 (02) : 279 - 281
  • [9] Effect of mibefradil on CYP3A4 in vivo
    Veronese, ML
    Gillen, LP
    Dorval, EP
    Hauck, WW
    Waldman, SA
    Greenberg, HE
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (10): : 1091 - 1100
  • [10] Investigations with a humanised CYP3A4/3A7 mouse model
    Doyle, Eddie
    Coutant, Anne-Laure
    Kapelyukh, Yury
    Boulenc, Xavier
    TOXICOLOGY LETTERS, 2014, 229 : S41 - S42